Identification of the interleukin-8 ( CXCL-8) pathway in feline oral squamous cell carcinoma - A pilot study
dc.contributor.author | Ackerman, Leah H. | |
dc.contributor.author | Souza, Carlos H. de Mello | |
dc.contributor.author | Cortes-Hinojosa, Galaxia | |
dc.contributor.author | Salute, Marc E. | |
dc.contributor.author | Stephen, Alexa A. | |
dc.contributor.author | Anthony, Elizabeth | |
dc.contributor.author | Shiomitsu, Keijiro | |
dc.contributor.author | Milner, Rowan J. | |
dc.date.accessioned | 2025-01-20T21:01:29Z | |
dc.date.available | 2025-01-20T21:01:29Z | |
dc.date.issued | 2022 | |
dc.description.abstract | The purpose of this pilot study was to detect the presence of interleukin-8 (IL-8) and the potential downstream effects of IL-8 receptor activation in 2 previously characterized feline oral squamous cell carcinoma cell lines ( SCCF1 and SCCF2). Interleukin-8 messenger RNA (mRNA) was initially detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR). A previously validated and commercially available enzyme-linked immunosorbent assay (ELISA) test was used to measure IL-8 production in the supernatant of the 2 cell lines. Western blot was used to detect phosphorylation of proteins (AKT, ERK1/2, JAK2, STAT3, and Src), known to be downstream of interleukin-8 receptor activation. The IL-8 receptor-specific antagonists, Reparixin and SCH527123, were used to identify effects on phosphorylation of these proteins. Interleukin-8 mRNA and protein were detected in both SCCF1 and SCCF2 by RT-PCR and ELISA, respectively. Phosphorylation of ERK1/2, STAT3, and Src was detected in both cell lines. Inhibition of the IL- 8 receptor led to a decrease in phosphorylation of Src, but not ERK1/2 or STAT3. In conclusion, feline squamous cell carcinoma cell lines can produce IL-8. Phosphorylation of Src seems, at least in part, a consequence of IL-8 receptor activation. The phosphorylation of ERK1/2 and STAT3, although present, seems independent of IL-8 receptor activation. Due to its potential effects on the tumor microenvironment, in addition to its autocrine effects on Src phosphorylation, the inhibition of the IL-8 receptor may become a beneficial therapeutic tool. Evaluation of the presence of both IL- 8 and Src in many cases should elucidate their importance. | |
dc.fuente.origen | WOS | |
dc.identifier.eissn | 1928-9022 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/92895 | |
dc.identifier.wosid | WOS:000880460400002 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.pagina.final | 19 | |
dc.pagina.inicio | 13 | |
dc.revista | Canadian journal of veterinary research-revue canadienne de recherche veterinaire | |
dc.rights | acceso restringido | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Identification of the interleukin-8 ( CXCL-8) pathway in feline oral squamous cell carcinoma - A pilot study | |
dc.type | artículo | |
dc.volumen | 86 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |